CAHP Statement: Assembly Health Committee Passes Bill to Stop Third Party Payer Scheme from Driving Up Health Care Costs for All

Legislation designed toincreaseconsumer protection by reining-in a profiteering scheme operated by the dialysis and drug rehabilitation industries passed the Assembly Health Committee on a bipartisan vote.

CAHP Statement: New RunawayRx Infographics Explain California’s Drug Price Transparency Law and How It’s Working to Reveal How Rx Costs Impact Health Plan Premiums

RunawayRx today released two new infographics. One highlightskey implementation dates for California’s landmark prescription drug transparency law, SB 17, and the other revealsnew details about how prescription drug costs are impacting California health plan premiums.

CAHP Statement: CAHP Issues Response to Newsom's State-of-the-State Address

California Association of Health Plans President and CEO Charles Bacchi issued a statement today in response to Governor Gavin Newsom’s first state-of-the-state address.

CAHP Statement: CAHP Issues Statement Applauding Governor’s Bold New Health Care Agenda

California Association of Health Plans (CAHP) President and CEO Charles Bacchi made a statement regarding Governor Gavin Newsom’s new health care agenda.

CAHP Statement: CAHP Joins California Health Care Community In Joint Media Statement Opposing ACA Ruling

If one can take a moment to make their way through the partisanship, the politics, and the perceptions (right or wrong), the Affordable Care Act is really about just one thing: people.

CAHP Statement: Federal Court Ruling Striking Down ACA

CAHP President and CEO Charles Bacchi made a statement regarding the District Court decision in TX v. United States of America on the constitutionality of the Affordable Care Act (ACA).

CAHP Statement: Renewed SB 17 Lawsuit Signals PhRMA’s Continued Unwillingness to Acknowledge Their Outsized Role in the High-Priced Drug Crisis

The Pharmaceutical Research and Manufacturers of America (PhRMA) has re-filed its lawsuit against SB 17, California’s drug price transparency legislation. PhRMA’s action comes just one month after a federal judge dismissed the organization’s previous lawsuit and offers a clear sign that the group intends to continue its efforts to keep patients in the dark about prescription drug pricing.

CAHP Statement: SB 1156 Supporters Undeterred by Governor’s Decision to Veto Bill

A broad coalition of concerned consumer, labor, and health care groups today expressed their disappointment in Governor Brown’s decision to veto SB 1156 -- a bill that would have discouraged certain dialysis providers and loosely regulated residential treatment centers throughout California from inappropriately shifting patients into commercial coverage in order to receive higher reimbursements for inflated and unnecessary medical claims. This practice has been particularly harmful to vulnerable individuals suffering from opioid addiction and kidney disease.

CAHP Statement: California Association of Health Plans President & CEO Releases Statement on 2019 Individual Market Rates

Covered California today announced health insurance rates for 2019, citing an average weighted statewide rate change of 8.7% as the exchange moves into its sixth year of operation. The rates reflect the ongoing changes to the Affordable Care Act at the federal level, particularly the decision to repeal the requirement to purchase health insurance coverage, as well as continued increased spending on medical care and several other factors.

CAHP Statement: The California Association of Health Plans Announces New Director of Legal and Regulatory Affairs

The California Association of Health Plans (CAHP) today announced that Stephanie Shirkey has joined its staff as Director of Legal and Regulatory Affairs. She will manage CAHP’s regulatory efforts with the Department of Managed Health Care (DMHC) and other stakeholders on behalf of CAHP’s 48 full-service health plans.

© California Association of Health Plans

Privacy Policy | Disclaimer